Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Arena Pharmaceuticals Inc. (ARNA): Today's Featured Drugs Winner
The Street
Saturday, August 18, 2012 - 3:36pm
tags:
Arena Pharmaceutical
Cambrex Signs New Supply Agreement
Yahoo/Zacks
Saturday, August 18, 2012 - 3:35pm
tags:
Cambrex
4 Cash-Heavy Large Cap Biotech Stocks That Analysts Rate As Buy
Seeking Alpha
Saturday, August 18, 2012 - 3:34pm
tags:
Amgen, Celgene, Alexion, Regeneron
Vivus Falls after Downgrade
Barron's
Saturday, August 18, 2012 - 3:33pm
tags:
Vivus, Qsymia, generics
Vivus Bulls: A Chance To Get In At $15.80 Or Earn An Extra 18.8%
Seeking Alpha
Saturday, August 18, 2012 - 3:32pm
tags:
Vivus
Earnings Miss at Repros
Yahoo/Zacks
Saturday, August 18, 2012 - 3:31pm
tags:
Repros Therapeutics, earnings
NovaBay Pharmaceuticals: Why It's A Good Idea To Act Now
Seeking Alpha
Friday, August 17, 2012 - 11:38am
tags:
NovaBay
VIVUS tumbles after firm says doctors may replace company's drug with generics
The Fly on the Wall
Friday, August 17, 2012 - 11:35am
tags:
Vivus, generics, obesity, Qsymia
AstraZeneca Wins This Summer's Pharma Acquisition Spree
Seeking Alpha
Friday, August 17, 2012 - 11:34am
tags:
M&A, AstraZeneca, Bristol-Myers Squibb, JNJ, Verastem, Eli Lilly, Pfizer
Teva and Ranbaxy start selling lower-cost version of Takeda's type 2 diabetes drug Actos
Yahoo/AP
Friday, August 17, 2012 - 11:23am
tags:
Teva Pharmaceuticals, Takeda, Ranbaxy, generics, diabetes, Actos
Ironwood Pharma: FDA Decision Expected Within Weeks For GI Drug
Seeking Alpha
Friday, August 17, 2012 - 11:22am
tags:
FDA, Ironwood, linaclotide, Forest Labs
The Men Who Run AstraZeneca
Motley Fool
Friday, August 17, 2012 - 11:19am
tags:
AstraZeneca
BioSante Pharmaceuticals to Raise $3,475,000 in Registered Direct Offering
Yahoo
Friday, August 17, 2012 - 10:36am
tags:
stock offering, BioSante
Pfizer Seen Circling Agila With U.S. Drug Shortages
Bloomberg
Friday, August 17, 2012 - 10:31am
tags:
Pfizer, drug shortages, Agila, India, Strides Arcolab
3 Big Reasons To Buy AstraZeneca Today
Seeking Alpha
Friday, August 17, 2012 - 10:29am
tags:
AstraZeneca, Eli Lilly, Novartis, GSK, Bristol-Myers Squibb
GSK drug halves attacks in hard-to-treat asthma
Reuters
Friday, August 17, 2012 - 10:22am
tags:
GSK, asthma, mepolizumab
Pharma To CMS: Where’s That Sunshine Rule?
Pharmalot
Friday, August 17, 2012 - 10:20am
tags:
Physician Payment Sunshine Act, CMS
Pfizer's Success With Its JAK Inhibitor
Seeking Alpha
Friday, August 17, 2012 - 10:18am
tags:
Pfizer, JAK inhibitors, Abbott Laboratories, Amgen, Bristol-Myers Squibb, tofacitinib, rheumatoid arthritis
Parkinson's Disease: 3 Different Firms, 3 Novel Approaches
Seeking Alpha
Thursday, August 16, 2012 - 1:47pm
tags:
Parkinson's Disease, Amicus, Impax Laboratories, International Stem Cell Corp
Bonalon Jelly 35 mg Approved as World’s First Oral Jelly for Osteoporosis
PharmaLive
Thursday, August 16, 2012 - 1:46pm
tags:
Bonalon Jelly, osteoporosis, Japan, Teijin Pharma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.